GBA1 and Parkinson disease: Similarly, no genotype-phenotype correlation was found between GCase enzymatic activity and disease severity outcomes in a cross-sectional study (57), suggesting that GCase enzymatic activity might not be a reliable marker of disease severity or progression in GBA1-PD.